Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...
Researchers have discovered a particular type of cancer cell that relies on its own biological electric utility company to thrive. Disrupting this power plant – with the help of a puffer fish – showed ...
Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.
PLLP may relate to SCLC's neuroendocrine features ... and PLLP may play a role in small cell lung cancer metabolism, immune response, and tumor progression, though more research is needed.
Doctors group them, depending on the place they start growing. For example, a lung neuroendocrine cancer starts in the lung. The place where the cancer starts is the primary cancer. If the cancer ...
But the terms mean the same thing. There are 2 key groups of neuroendocrine cancer: neuroendocrine tumours (NETs) neuroendocrine carcinomas (NECs) Neuroendocrine cancer can start in any part of the ...
Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in cancer cells to help tumors grow.
Small cell lung cancer (SCLC ... myeloid leukemia—are being investigated for their ability to inhibit neuroendocrine tumor growth in both normal and MYC-amplified variants.
The following is a summary of “Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer,” published in ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results